These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor. van den Bent MJ Clin Cancer Res; 2005 Mar; 11(5):1691-3. PubMed ID: 15755989 [No Abstract] [Full Text] [Related]
4. Acetyl-L-carnitine undervalued in the treatment of chemotherapy-induced peripheral neuropathy? van Dam DG; Beijers AJ; Vreugdenhil G Acta Oncol; 2016 Dec; 55(12):1495-1497. PubMed ID: 27606940 [No Abstract] [Full Text] [Related]
5. Chemotherapy-induced peripheral neuropathy: Current status and progress. Brewer JR; Morrison G; Dolan ME; Fleming GF Gynecol Oncol; 2016 Jan; 140(1):176-83. PubMed ID: 26556766 [TBL] [Abstract][Full Text] [Related]
6. Editorial: Supplements and Chemotherapy-Induced Peripheral Neuropathy: Hope or Hype? Ligibel JA J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 30053079 [No Abstract] [Full Text] [Related]
8. Chemotherapy-induced peripheral neuropathy: a new treatment option. Enck RE Am J Hosp Palliat Care; 2012 Nov; 29(7):509-11. PubMed ID: 23074287 [No Abstract] [Full Text] [Related]
9. Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement. Dunlap B; Paice JA J Support Oncol; 2006 Sep; 4(8):398-9. PubMed ID: 17004514 [No Abstract] [Full Text] [Related]
12. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study. Almadrones L; McGuire DB; Walczak JR; Florio CM; Tian C Oncol Nurs Forum; 2004 May; 31(3):615-23. PubMed ID: 15146227 [TBL] [Abstract][Full Text] [Related]
13. Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness. Teoh D; Smith TJ; Song M; Spirtos NM Am Soc Clin Oncol Educ Book; 2018 May; 38():469-479. PubMed ID: 30231411 [TBL] [Abstract][Full Text] [Related]
14. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug. van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Schloss JM; Colosimo M; Airey C; Vitetta L Support Care Cancer; 2015 Jul; 23(7):1843-50. PubMed ID: 25863665 [No Abstract] [Full Text] [Related]
16. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. Gilchrist L Semin Pediatr Neurol; 2012 Mar; 19(1):9-17. PubMed ID: 22641071 [TBL] [Abstract][Full Text] [Related]
17. Managing Neuropathy After Chemotherapy in Patients With Cancer. Holz SC; Wininger YD; Cooper C; Smith SR Arch Phys Med Rehabil; 2017 Mar; 98(3):605-607. PubMed ID: 28232002 [No Abstract] [Full Text] [Related]
18. [Peripheral neuropathy produced by cisplatin]. Valero Jiménez P; Murillo Capitán E; Sánchez Romero JA; Arbizu Ladrón de Guevara ML Rev Esp Oncol; 1984; 31(3):511-3. PubMed ID: 6085937 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015 [TBL] [Abstract][Full Text] [Related]
20. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine. Griffiths JD; Stark RJ; Ding JC; Cooper IA Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]